Department of Medical Services to Study microRNA Blood Test to Help Screen for Colorectal Cancer in Thailand

Published 2026-10-26

The Department of Medical Services, through the National Cancer Institute, is collaborating with MiRXES, a developer of molecular diagnostic technology, and N Health to study an innovative microRNA blood test. This partnership aims to improve colorectal cancer screening in Thailand.

Colorectal cancer is a commonly found cancer in Thailand. Detecting abnormalities at an early stage can increase the likelihood of successful treatment. Currently, some screening methods, such as colonoscopy, may cause patients discomfort and may not allow everyone to be examined thoroughly. Therefore, new and easier testing methods are being studied.

MicroRNAs are small molecules found in the blood and other biological fluids of the body. These molecules may change when cells begin to become abnormal. A blood test may therefore help indicate the risk of the disease. However, the information published so far is only an announcement of the collaboration, with no details yet about the number of participants, the study duration, or the test results.

If the study yields beneficial results, this type of testing could make colorectal cancer screening more accessible to the public in the future. Those interested can follow further news from the Department of Medical Services and the National Cancer Institute.

Sources: แนวหน้า

More Thailand news

All Thailand news · News by country